| Ms Majerle Bunce, CRNA | |
|
3333 Evergreen Dr Ne, Grand Rapids, MI 49525-9493 | |
| (616) 364-4200 | |
| (616) 364-7347 |
| Full Name | Ms Majerle Bunce |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 4 Years |
| Location | 3333 Evergreen Dr Ne, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023604972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1029009 (Texas) | Primary |
| 163WC0200X | Registered Nurse - Critical Care Medicine | 878444 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spectrum Health Big Rapids Hospital | Big rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Michigan Anesthesia Pc | 1355243551 | 193 |
News Archive
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published in an upcoming edition of Breast Cancer Research, a prominent peer-reviewed medical journal.
Six years ago, as a 19-year-old college sophomore, Jennifer Staple decided to battle preventable blindness so she started the nonprofit "Unite for Sight" with a staff of one: herself.
Mylan Inc. today announced that its subsidiary Mylan Specialty L.P. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levalbuterol Inhalation Solution USP, 0.31 mg/3 mL (0.0103%), 0.63 mg/3 mL (0.021%), and 1.25 mg/3 mL (0.042%), (Concentrate).
MedScope, the leading developer and marketer of high tech medical alert systems, has announced its new two-way communication mobile Personal Emergency Response System (mPERS), that can be used anywhere, is now available.
› Verified 7 days ago
| Entity Name | West Michigan Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225016926 PECOS PAC ID: 1355243551 Enrollment ID: O20040127000018 |
News Archive
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published in an upcoming edition of Breast Cancer Research, a prominent peer-reviewed medical journal.
Six years ago, as a 19-year-old college sophomore, Jennifer Staple decided to battle preventable blindness so she started the nonprofit "Unite for Sight" with a staff of one: herself.
Mylan Inc. today announced that its subsidiary Mylan Specialty L.P. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levalbuterol Inhalation Solution USP, 0.31 mg/3 mL (0.0103%), 0.63 mg/3 mL (0.021%), and 1.25 mg/3 mL (0.042%), (Concentrate).
MedScope, the leading developer and marketer of high tech medical alert systems, has announced its new two-way communication mobile Personal Emergency Response System (mPERS), that can be used anywhere, is now available.
› Verified 7 days ago
| Entity Name | Anesthesia Medical Consultants, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063710689 PECOS PAC ID: 3678751658 Enrollment ID: O20110621000722 |
News Archive
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published in an upcoming edition of Breast Cancer Research, a prominent peer-reviewed medical journal.
Six years ago, as a 19-year-old college sophomore, Jennifer Staple decided to battle preventable blindness so she started the nonprofit "Unite for Sight" with a staff of one: herself.
Mylan Inc. today announced that its subsidiary Mylan Specialty L.P. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levalbuterol Inhalation Solution USP, 0.31 mg/3 mL (0.0103%), 0.63 mg/3 mL (0.021%), and 1.25 mg/3 mL (0.042%), (Concentrate).
MedScope, the leading developer and marketer of high tech medical alert systems, has announced its new two-way communication mobile Personal Emergency Response System (mPERS), that can be used anywhere, is now available.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Majerle Bunce, CRNA 3333 Evergreen Dr Ne, Grand Rapids, MI 49525-9493 Ph: (616) 364-4200 | Ms Majerle Bunce, CRNA 3333 Evergreen Dr Ne, Grand Rapids, MI 49525-9493 Ph: (616) 364-4200 |
News Archive
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published in an upcoming edition of Breast Cancer Research, a prominent peer-reviewed medical journal.
Six years ago, as a 19-year-old college sophomore, Jennifer Staple decided to battle preventable blindness so she started the nonprofit "Unite for Sight" with a staff of one: herself.
Mylan Inc. today announced that its subsidiary Mylan Specialty L.P. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levalbuterol Inhalation Solution USP, 0.31 mg/3 mL (0.0103%), 0.63 mg/3 mL (0.021%), and 1.25 mg/3 mL (0.042%), (Concentrate).
MedScope, the leading developer and marketer of high tech medical alert systems, has announced its new two-way communication mobile Personal Emergency Response System (mPERS), that can be used anywhere, is now available.
› Verified 7 days ago
Anne Marie Talbot, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 Jefferson Ave Se, Grand Rapids, MI 49503 Phone: 616-685-6063 Fax: 616-685-3092 | |
Mrs. Lindsay E Mckelvey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Mrs. Heather M Montgomery-kanitz, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Courtney Kolanowski, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 Jefferson Ave Se, Grand Rapids, MI 49503 Phone: 616-685-5000 | |
Mr. Patrick James Evans, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Mr. Brent Zukoff, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Grand Rapids, MI 49503 Phone: 616-391-1774 |